Hormone replacement therapy (oestradiol-only preparations): can the laboratory recommend a concentration of plasma oestradiol to protect against osteoporosis?
Hormone replacement therapy (oestradiol-only preparations): can the laboratory recommend a concentration of plasma oestradiol to protect against osteoporosis?
Target concentrations of plasma oestradiol to protect against osteoporosis have now been published in at least one textbook and are increasingly discussed by clinicians. A survey of the literature revealed that many reports do not give details of oestradiol assay methods, despite the fact that there is a wide range of biases. Plasma oestradiol measurements made after ingestion of equine oestrogen preparations are not valid, and for oral oestradiol and oestradiol valerate preparations a single untimed sample does not give a reliable estimate of the average exposure over 24 h. Oestradiol measurements in plasma from women using patch, gel or implant preparations could be useful provided that consideration is given to the time of sampling and to the assay method used, although target levels have not been established. Further studies are required in this area.
dose-response relationship, administration & dosage, bone density, drug therapy, pathology, hormone replacement therapy, estrogen replacement therapy, horses, radioimmunoassay, report, plasma, methods, humans, oral, literature, drug, animals, administration, pharmacokinetics, time factors, blood, female, osteoporosis, exposure, estradiol, time, treatment outcome, therapeutic use, therapy, laboratories
184-193
Armston, A.
3a35567b-9d5a-4c2e-bcbb-ce6efef16aa2
Wood, P.
24642270-7542-4923-ba8c-2780e8601d81
2002
Armston, A.
3a35567b-9d5a-4c2e-bcbb-ce6efef16aa2
Wood, P.
24642270-7542-4923-ba8c-2780e8601d81
Armston, A. and Wood, P.
(2002)
Hormone replacement therapy (oestradiol-only preparations): can the laboratory recommend a concentration of plasma oestradiol to protect against osteoporosis?
Annals of Clinical Biochemistry, 39 (3), .
(doi:10.1258/0004563021902107).
Abstract
Target concentrations of plasma oestradiol to protect against osteoporosis have now been published in at least one textbook and are increasingly discussed by clinicians. A survey of the literature revealed that many reports do not give details of oestradiol assay methods, despite the fact that there is a wide range of biases. Plasma oestradiol measurements made after ingestion of equine oestrogen preparations are not valid, and for oral oestradiol and oestradiol valerate preparations a single untimed sample does not give a reliable estimate of the average exposure over 24 h. Oestradiol measurements in plasma from women using patch, gel or implant preparations could be useful provided that consideration is given to the time of sampling and to the assay method used, although target levels have not been established. Further studies are required in this area.
This record has no associated files available for download.
More information
Published date: 2002
Keywords:
dose-response relationship, administration & dosage, bone density, drug therapy, pathology, hormone replacement therapy, estrogen replacement therapy, horses, radioimmunoassay, report, plasma, methods, humans, oral, literature, drug, animals, administration, pharmacokinetics, time factors, blood, female, osteoporosis, exposure, estradiol, time, treatment outcome, therapeutic use, therapy, laboratories
Identifiers
Local EPrints ID: 59452
URI: http://eprints.soton.ac.uk/id/eprint/59452
ISSN: 0004-5632
PURE UUID: 45d091ff-3e91-49aa-81b2-c82b8076ded7
Catalogue record
Date deposited: 02 Sep 2008
Last modified: 15 Mar 2024 11:16
Export record
Altmetrics
Contributors
Author:
A. Armston
Author:
P. Wood
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics